November 12, 2019
A New Webinar has been scheduled for November 19 at 2 pm EST for your law firm to learn more about the Zantac litigation. The webinar is put on by CAMG and your host will be Steve Nober. The leading attorneys on the Zantac litigation will be debunking the recent FDA statement on Zantac Link here.
Neil D. Overholtz and R. Jason Richard from Aylstock, Witkin, Kreis & Overholtz will be presenting together with Robert C. Hilliard from Hilliard Martinez Gonzales LLP. This will be the attorneys moving this litigation forward. They have already done all the research on the Zantac and if you are interested in the Zantac litigation you want to be on this call.
Please click on the image on the bottom bellow to sign up.
X Social Media always has up-to-date lead information on our website for the first full month of running Zantac with no dis-qualifiers.The information is located here on our website; for people looking only for qualified cancers for Zantac that is coming in right around $200 per lead.
Sign Up Now › |
Zantac Cancer Risk
So what the hell right ? 35 years on the market and now they tell us that its cancer causing?
Ranitidine likely generates millions of nanograms of NDMA in humans where the FDA maximum permissible daily exposure of the probable human carcinogen, NDMA, in pharmaceuticals is 96 ng.
How do we move Forward?
There are a few ways of looking at this developing MDL as we see it. First, you have exposure of millions of people to a cancer causing substance NDMA for 35+ years. Many will end up with different cancers over their lifetime and a known source of this cancer will be Zantac. This would mean you sign up everybody that has taken Zantac and you guys make an MDL that has two tracks one being exposure and one being cancer.Another way of looking at it would be signing up people that have already developed a cancer that Zantac could have caused. Like Bladder Cancer, Stomach cancers and a total of 8 different cancers can be tied to this. We can then use the landing page to Disqualify people that have not developed a qualifying cancer and only send the qualifying cancers though to an intake center for signing-up.For the advertising attorneys- we already have a few big names that cases can be referred to just ask us for introductions to ref. firms.
What do we know so far about prices per lead?
In the last 3 weeks we have been running about a million dollars in advertising spend towards this target market and here is what we know.If you are just looking for anybody that took Zantac with a qualifying cancer or not we see prices of $30-40 per lead and we see huge volume even on big spends.If you want to disqualify people so only people diagnosed with the correct cancer is coming though we see prices of $175-$200 per lead.
|
|
|
A Great Read To Learn Facebook Advertising For Law Firms